查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1809935

DNA 片段市場按類型、產品類型、技術、應用和最終用戶分類—全球預測，2025-2030 年

DNA Fragments Market by Type, Product Type, Technology, Application, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計 2024 年 DNA 片段市場價值將達到 21.8 億美元，2025 年將成長至 23.5 億美元，到 2030 年將達到 34.9 億美元，複合年成長率為 8.17%。

主要市場統計數據
基準年2024年 21.8億美元
預計2025年 23.5億美元
預測年份 2030 34.9億美元
複合年成長率（%） 8.17%

揭示DNA片段研發背後的根本驅動力：驚人的科學突破塑造了生物技術前沿

在快速發展的生物技術領域，DNA片段已成為研究人員和產業領袖的重要工具。這些短核苷酸序列構成了從基因編輯到診斷檢測等無數應用的基礎。隨著對基因組學的科學理解不斷加深，操縱和分析DNA片段的能力為探索細胞機制和疾病途徑提供了前所未有的精確度。

探索將徹底改變 DNA 片段合成及其在生物技術中的應用的技術和科學模式轉移

近年來，科技進步浪潮深刻地改變了DNA片段的合成、分析和應用方式。高通量定序平台如今擁有無與倫比的準確性和速度，使研究人員能夠以單一鹼基解析度解析片段組成。同時，酶促和化學合成通訊協定的改進顯著縮短了周轉時間，促使人們從大規模生產轉向高度客製化的片段庫，以滿足特定的研究需求。

評估 2025 年美國關稅對 DNA 片段產業的深遠影響，這將改變供應鏈和監管格局

2025年美國新關稅的實施，為依賴DNA片段及相關試劑跨境貿易的組織帶來了複雜的挑戰。隨著關鍵起始材料被徵收進口關稅，成本結構正在重新平衡，迫使供應商和最終用戶重新評估供應鏈的彈性和營運成本。這些調整正層層遞進，影響上游生產設施和下游實驗室。

揭示關鍵的細分動態，揭示不同的 DNA 片段類型、技術、應用和使用者資料如何塑造市場機會

透過多種細分視角審視市場動態，可以對其有更細緻的理解。 DNA片段的類型可分為雙鏈片段和單鏈片段，前者因其在克隆和基因組組裝中的穩定性而備受推崇，而後者正擴大被用於靶向寡核苷酸治療和精準基因探測。從生物來源提取的天然DNA與精確規格化學組裝的合成DNA之間的區別，進一步明確了使用者偏好和應用適用性。

區域成長軌跡分析表明，美洲、歐洲、中東和非洲以及亞太地區是 DNA 片段進步的關鍵區域

了解區域特性對於理解DNA片段化研究在世界各地的進展至關重要。在美洲，強大的研究基礎設施和大量的私人投資使該地區在商業性試劑開發和先進治療研究方面處於領先地位。領先的學術中心和產業合作夥伴之間的合作正在推動基於片段的診斷和個人化醫療的創新。

聚焦推動 DNA 碎片化能力和合作研究突破的領先產業相關人員的策略定位和創新

DNA片段化領域的主要相關人員以其對平台整合、自動化和協作的策略重點而聞名。領先的公司正在透過有針對性的收購以及與專業試劑開發商的合作來擴展其產品組合，從而拓展其技術產品線和全球分銷範圍。透過投資從片段設計軟體到高通量合成和品管分析的端到端解決方案，這些公司憑藉其服務的廣度和可靠性脫穎而出。

制定實用的產業建議，以提高效率、推動創新並在 DNA 片段研究環境中保持競爭優勢

為了在這種動態環境中取得成功，產業領導者應採取多管齊下的方法，優先考慮技術卓越性和營運敏捷性。投資自動化合成和分析平台可以顯著縮短週轉時間並最大限度地減少人為錯誤。輔以強大的品管通訊協定，可以增強客戶信心並滿足合規性要求。

了解整合資料收集、分析和檢驗技術的強大調查方法，從而深入了解全面的 DNA 片段

這項綜合分析採用了一手資料和二手資料相結合的方法，以確保洞察的深度和可靠性。一手資料研究包括與頂尖研究人員、採購專家和監管專家進行的結構化訪談，他們就技術採用、供應鏈動態和關稅影響提供了定性觀點。此外，我們還對來自學術、臨床和工業領域的實驗室管理人員和最終用戶進行了深入的問卷調查，作為這些訪談的補充。

整合關鍵發現和策略觀點，闡明未來發展道路並推動 DNA 片段研究的持續進步

本摘要了主要發現，重點介紹了先進的合成和分析技術對 DNA 片段格局的變革性影響。 2025 年的關稅變化凸顯了供應鏈敏捷性和策略採購的重要性，而技術創新則持續推動片段製造的精準度和效率。細分分析揭示了不同類型、技術、應用和最終用戶類別之間的細微偏好，為有針對性的策略發展提供了藍圖。

目錄

第1章：前言

第2章調查方法

第3章執行摘要

第4章 市場概況

第5章市場動態

  • 按需台式 DNA 片段合成器改變了學術界和工業界的研究工作流程
  • 基因治療市場對 GMP 級 DNA 片段的需求不斷成長，推動了生產規模的擴大
  • 高通量 DNA 片段合成技術的進步提高了整個生物技術產業的成本效率
  • 整合人工智慧引導設計平台可提高客製化 DNA 片段組裝的準確性
  • 酵素組裝方法的出現，降低了合成 DNA 片段建構過程中的錯誤率
  • 不斷發展的法規結構，以確保商業性DNA 片段製造的品質和安全
  • 擴展多重 DNA 片段庫以實現藥物研發流程中的快速篩檢
  • 生技公司與學術實驗室之間的策略合作，加速 DNA 片段化技術的創新

第6章 市場洞察

  • 波特五力分析
  • PESTEL分析

第7章 2025年美國關稅的累積影響

8. DNA片段市場類型

  • 雙鏈
  • 單鏈

第9章 DNA 片段市場（依產品類型）

  • 天然DNA
  • 合成DNA

第 10 章 DNA 片段市場（依技術）

  • 化學合成
  • 酵素合成
  • 基於PCR的擴增

第 11 章 DNA 片段市場（依應用）

  • 生物技術
    • 生物資訊學
    • 生物技術
  • 醫療保健
    • 診斷
    • 治療
  • 研究與開發

第 12 章 DNA 片段市場（按最終用戶）

  • 學術和研究機構
  • CRO
  • 醫院和診所
  • 製藥公司

13.美洲DNA片段市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 阿根廷

14. 歐洲、中東和非洲的 DNA 片段市場

  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 阿拉伯聯合大公國
  • 沙烏地阿拉伯
  • 南非
  • 丹麥
  • 荷蘭
  • 卡達
  • 芬蘭
  • 瑞典
  • 奈及利亞
  • 埃及
  • 土耳其
  • 以色列
  • 挪威
  • 波蘭
  • 瑞士

15. 亞太地區DNA片段市場

  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國
  • 印尼
  • 泰國
  • 菲律賓
  • 馬來西亞
  • 新加坡
  • 越南
  • 台灣

第16章競爭格局

  • 2024年市佔率分析
  • 2024年FPNV定位矩陣
  • 競爭分析
    • Abbott Laboratories
    • Agilent Technologies, Inc.
    • Ansa Biotechnologies, Inc.
    • Azenta Life Sciences
    • Abcam plc
    • DNA TwoPointO Inc.
    • Eurofins Scientific SE
    • Gene Universal, Inc.
    • GenScript Biotech Corporation
    • Illumina, Inc.
    • Integrated DNA Technologies, Inc. by Danaher Corporation
    • Merck KGaA
    • Meridian Bioscience, Inc.
    • Novartis AG
    • Pacific Biosciences of California, Inc.
    • QIAGEN NV
    • Synbio Technologies LLC
    • Takara Co., Ltd.
    • Thermo Fisher Scientific Inc.
    • Twist Bioscience Corporation
    • Synbio Technologies Private Limited
    • Cell Signaling Technology, Inc..
    • Bio-Rad Laboratories, Inc.
    • SCSA Diagnostics Inc.
    • Profacgen

第17章 研究人工智慧

第18章 研究統計

第19章 研究聯絡人

第20章 研究報導

第21章 附錄

Product Code: MRR-6E3B3C6D0807

The DNA Fragments Market was valued at USD 2.18 billion in 2024 and is projected to grow to USD 2.35 billion in 2025, with a CAGR of 8.17%, reaching USD 3.49 billion by 2030.

KEY MARKET STATISTICS
Base Year [2024] USD 2.18 billion
Estimated Year [2025] USD 2.35 billion
Forecast Year [2030] USD 3.49 billion
CAGR (%) 8.17%

Unveiling the Fundamental Drivers of DNA Fragment Research and Development Shaping the Biotech Frontier with Impactful Scientific Breakthroughs

In the rapidly evolving landscape of biotechnology, DNA fragments have become a vital tool for researchers and industry leaders alike. These short sequences of nucleotides serve as the building blocks for a myriad of applications, ranging from gene editing to diagnostic assays. As scientific understanding of genomics deepens, the ability to manipulate and analyze discrete fragments of DNA offers unprecedented precision in exploring cellular mechanisms and disease pathways.

This executive summary delves into the core dynamics driving the prominence of DNA fragments. It highlights the convergence of advanced synthesis techniques with high-throughput analytical platforms, enabling breakthroughs that were once deemed impossible. Moreover, the intersection of computational biology and synthetic chemistry is expanding the boundaries of what can be achieved, paving the way for novel therapeutic candidates and expedited research workflows.

Throughout this introduction, emphasis is placed on the fundamental drivers that have propelled DNA fragment technology to the forefront of modern life sciences. By laying this foundation, readers will gain clarity on the interconnected factors-scientific, technological, and regulatory-that are shaping the current environment. As we transition into an exploration of transformative shifts, this section underlines the critical importance of DNA fragments as an engine for innovation across multiple sectors.

Exploring the Revolutionary Technological and Scientific Paradigm Shifts Revolutionizing DNA Fragment Synthesis Analysis and Application across Biotech Sectors

Across recent years, a wave of technological and scientific advancements has reshaped how DNA fragments are synthesized, analyzed, and applied. High-throughput sequencing platforms now offer unparalleled accuracy and speed, enabling researchers to decode fragment compositions with single-nucleotide resolution. Concurrently, improved enzymatic and chemical synthesis protocols have significantly reduced turnaround times, fueling a shift from large-scale production to highly customized fragment libraries tailored to specific research needs.

Moreover, the advent of automated liquid handling systems and integrated microfluidic devices has streamlined workflows that once demanded extensive manual intervention. These integrated solutions not only enhance reproducibility but also lower the barriers for smaller research teams to adopt cutting-edge methods. In parallel, developments in machine learning algorithms have transformed data analysis, empowering scientists to uncover hidden patterns within complex fragment datasets and predict structural or functional outcomes with increasing confidence.

Consequently, the ecosystem surrounding DNA fragments is no longer confined to traditional academic and clinical settings. Innovative start-ups and established life science firms alike are collaborating to bring multiplexed assays, novel gene therapies, and precision biomanufacturing processes to market. As these paradigm shifts continue to unfold, the interplay between technological refinements and translational research promises to unlock new frontiers in healthcare, agriculture, and environmental applications.

Assessing the Far-Reaching Consequences of 2025 United States Tariffs on DNA Fragment Industries Transforming Supply Chains and Regulatory Landscapes

The introduction of new United States tariffs in 2025 has introduced complex challenges for organizations relying on cross-border trade of DNA fragments and related reagents. Cost structures have been recalibrated as import duties are applied to critical starting materials, compelling suppliers and end-users to reassess supply chain resilience and operational expenditure. These adjustments have reverberated across upstream production facilities as well as downstream research laboratories.

In response, many stakeholders have initiated efforts to diversify procurement strategies, seeking alternative suppliers in regions with more favorable trade agreements. Manufacturers are exploring near-shoring options to mitigate tariff impacts, while logistics providers adjust routing and warehousing plans to optimize total landed costs. At the same time, regulatory compliance protocols have become more intricate as documents and certifications must align with evolving tariff classifications and customs requirements.

Despite these disruptions, the industry's adaptive capacity has been notable. Collaborative purchasing consortia have emerged as a mechanism to consolidate volumes and negotiate better terms, and some solution providers have introduced tariff-inclusive pricing models to simplify budgeting. As we examine segmentation insights, it becomes clear that the ability to navigate these tariff-related complexities will be a defining factor in maintaining competitive advantage and ensuring continuity of critical research and development initiatives.

Unraveling Key Segmentation Dynamics Illuminating How Diverse DNA Fragment Types Technologies Applications and User Profiles Shape Market Opportunities

A nuanced understanding of market dynamics emerges when examining the landscape through multiple segmentation lenses. Based on type, the field distinguishes between double-stranded fragments, prized for their stability in cloning and genome assembly, and single-stranded fragments, which are increasingly utilized in targeted oligonucleotide therapies and precise genetic probing. The distinction between natural DNA, extracted from biological sources, and synthetic DNA, chemically assembled to exact specifications, further delineates user preferences and application fit.

Technological segmentation reveals a trifurcation: chemical synthesis methods offer rapid, high-fidelity production for short to moderate fragment lengths; enzymatic synthesis leverages polymerases to extend sequences with high yields; and PCR-based amplification remains a workhorse for generating fragments of defined endpoints. Each approach carries unique cost, speed, and error-rate profiles, influencing its selection in research and applied settings.

Application-focused analysis spans biotechnology, medical, and R&D domains. In biotechnology, the integration of bioinformatics and molecular engineering is unlocking advanced functional studies, while medical contexts include diagnostics assays to detect genetic markers and therapeutic constructs for gene correction. Within research and development, academic and industry scientists employ fragments to elucidate fundamental biological mechanisms.

Finally, end-users range from academic and research institutes cultivating foundational science to contract research organizations offering specialized services, as well as hospitals, clinics, and pharmaceutical companies driving translational and commercialization efforts. Together, these segmentation insights illuminate the multifaceted drivers that shape priorities, investments, and technology adoptions across the spectrum.

Dissecting Regional Growth Trajectories Highlighting the Americas Europe Middle East Africa and Asia Pacific as Pivotal Arenas for DNA Fragment Advancements

Regional characteristics are pivotal in understanding how DNA fragment initiatives unfold across the globe. In the Americas, robust research infrastructure and significant private investment have positioned the region at the forefront of commercial reagent development and advanced therapeutic research. Collaboration between leading academic centers and industry partners drives innovation in fragment-based diagnostics and personalized medicine.

Europe, the Middle East and Africa exhibit a rich tapestry of regulatory frameworks and funding mechanisms. European nations benefit from coordinated research programs and standardized regulatory pathways that facilitate clinical trial approvals, while emerging markets within the Middle East and Africa are quickly establishing centers of excellence to address local health challenges using fragment technologies. Harmonization efforts are underway to streamline cross-border collaborations and knowledge sharing.

In the Asia-Pacific region, a blend of manufacturing scale-up and rapid adoption of novel biotechnologies underscores strong growth momentum. Countries with established life science clusters are investing heavily in capacity expansion for synthetic fragments, whereas emerging economies are focusing on building skilled talent pools and infrastructure to support diagnostic applications. Cross-regional partnerships are emerging to balance cost-effective production with regulatory alignment, creating a dynamic environment for next-generation fragment solutions.

Spotlighting the Strategic Positioning and Innovations of Leading Industry Stakeholders Driving Breakthroughs in DNA Fragment Capabilities and Collaborations

Leading stakeholders in the DNA fragment arena are distinguished by their strategic emphasis on platform integration, automation, and collaborative research. Key players have expanded their portfolios through targeted acquisitions and partnerships with specialized reagent developers, thereby broadening their technology offerings and global distribution networks. Investment in end-to-end solutions-from fragment design software to high-throughput synthesis and quality control analytics-has enabled these organizations to differentiate on service breadth and reliability.

Innovation pipelines have been bolstered by strategic alliances with academic institutions and biotech start-ups, accelerating the commercialization of novel fragment applications. Additionally, some companies are pioneering modular instrument designs that allow users to customize workflows according to project requirements, fostering both operational flexibility and scalability. In parallel, tiered pricing strategies and consumable subscription models have emerged, facilitating easier budgeting for research laboratories and clinical facilities.

As data integrity becomes increasingly critical, enterprises are implementing advanced informatics platforms to track fragment provenance, synthesis parameters, and performance metrics. This holistic approach to data management not only enhances reproducibility but also supports regulatory submissions and intellectual property protections. Collectively, these strategic moves underscore the central role that integrated service models and technological synergy play in shaping competitive positioning within the DNA fragment landscape.

Formulating Pragmatic Industry Recommendations to Boost Efficiency Drive Innovation and Maintain Competitive Edge in DNA Fragment Research Environment

To thrive in this dynamic environment, industry leaders should adopt a multifaceted approach that prioritizes both technological excellence and operational agility. Investing in automated synthesis and analysis platforms can significantly reduce turnaround times and minimize human error, enabling faster progression from concept to application. Complementing these investments with robust quality management protocols will strengthen customer confidence and support compliance requirements.

Diversifying supply chain partnerships is essential to mitigate risks associated with geopolitical shifts and trade policies. Engaging multiple suppliers across different regions will enhance resilience and ensure continuity of critical reagent availability. Concurrently, fostering open innovation through collaborative research agreements with academic centers and technology incubators can accelerate development cycles and unlock new fragment applications.

Embracing digital transformation initiatives-such as advanced data analytics, predictive modeling, and cloud-based collaboration tools-will empower organizations to optimize resource allocation and derive deeper insights from fragment performance data. Finally, dedicating resources to sustainability practices, including green chemistry synthesis and waste reduction, will align operations with emerging environmental standards and support long-term societal responsibility.

Detailing a Robust Research Methodology Integrating Data Collection Analysis and Validation Techniques Underpinning Comprehensive DNA Fragment Insights

This comprehensive analysis draws upon a blend of primary and secondary research methodologies to ensure depth and reliability of insights. Primary sources include structured interviews with leading researchers, procurement specialists, and regulatory experts who provided qualitative perspectives on technology adoption, supply chain dynamics, and tariff impacts. These conversations were supplemented by detailed questionnaire surveys targeting laboratory managers and end-users across academic, clinical, and industrial segments.

Secondary sources encompass peer-reviewed scientific literature, patent filings, regulatory agency publications, and publicly available corporate disclosures. Advanced text-mining techniques were applied to distill trends from large volumes of technical documents, while bespoke data-validation protocols ensured consistency and accuracy. Expert panels convened at multiple stages to review findings, challenge assumptions, and refine segment definitions.

Quantitative data points were cross-verified with industry benchmarks and historical performance indicators to confirm their relevance. The resulting dataset was synthesized through a structured framework that mapped technological capabilities, cost factors, and regulatory considerations against segment-specific priorities. This rigorous methodological approach underpins the robustness and actionable nature of the insights presented throughout the report.

Synthesizing Critical Findings and Strategic Perspectives to Illuminate Future Pathways and Catalyze Continued Advancement in DNA Fragment Research

Bringing together the critical findings, this summary underscores the transformative impact of advanced synthesis and analytical technologies on the DNA fragment landscape. The 2025 tariff changes have highlighted the importance of supply chain agility and strategic sourcing, while technological innovations continue to drive precision and efficiency in fragment production. Segmentation analysis reveals nuanced preferences across types, technologies, applications, and end-user categories, providing a roadmap for targeted strategy development.

Regional insights illustrate distinct growth trajectories, with the Americas leading in commercial reagent development, Europe, the Middle East and Africa fostering collaborative regulatory environments, and the Asia-Pacific region scaling manufacturing capabilities. Strategic actions by industry stakeholders-from platform integration to data management-emphasize the value of comprehensive service models and digital infrastructure.

Moving forward, companies that invest in automation, diversify procurement, and embrace open innovation will be well-positioned to capitalize on emerging opportunities. The methodological rigor applied in this analysis ensures that decision-makers can rely on these insights to guide investments and shape research priorities. Ultimately, this report serves as a catalyst for continued advancement, offering a clear vision of how DNA fragments will drive the next generation of biotechnological breakthroughs.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Market Sizing & Forecasting

5. Market Dynamics

  • 5.1. Rise of on-demand benchtop DNA fragment synthesizers transforming academic and industrial research workflows
  • 5.2. Growing demand for GMP-grade DNA fragments in gene therapy market fueling scale-up of production
  • 5.3. Advancements in high-throughput DNA fragment synthesis driving cost efficiencies across biotech industry
  • 5.4. Integration of AI-guided design platforms accelerating precision in custom DNA fragment assembly
  • 5.5. Emergence of enzymatic assembly methods reducing error rates in synthetic DNA fragment construction
  • 5.6. Regulatory frameworks evolving to ensure quality and safety in commercial DNA fragment manufacturing
  • 5.7. Expansion of multiplexed DNA fragment libraries enabling rapid screening in drug discovery pipelines
  • 5.8. Strategic collaborations between biotech firms and academic labs enhancing innovation in DNA fragment technologies

6. Market Insights

  • 6.1. Porter's Five Forces Analysis
  • 6.2. PESTLE Analysis

7. Cumulative Impact of United States Tariffs 2025

8. DNA Fragments Market, by Type

  • 8.1. Introduction
  • 8.2. Double-Stranded
  • 8.3. Single-Stranded

9. DNA Fragments Market, by Product Type

  • 9.1. Introduction
  • 9.2. Natural DNA
  • 9.3. Synthetic DNA

10. DNA Fragments Market, by Technology

  • 10.1. Introduction
  • 10.2. Chemical Synthesis
  • 10.3. Enzymatic Synthesis
  • 10.4. PCR Based Amplification

11. DNA Fragments Market, by Application

  • 11.1. Introduction
  • 11.2. Biotechnology
    • 11.2.1. Bioinformatics
    • 11.2.2. Biotechnology
  • 11.3. Medical
    • 11.3.1. Diagnostics
    • 11.3.2. Therapeutics
  • 11.4. Research & Development

12. DNA Fragments Market, by End-User

  • 12.1. Introduction
  • 12.2. Academic & Research Institutes
  • 12.3. Contract Research Organizations
  • 12.4. Hospitals & Clinics
  • 12.5. Pharmaceutical Companies

13. Americas DNA Fragments Market

  • 13.1. Introduction
  • 13.2. United States
  • 13.3. Canada
  • 13.4. Mexico
  • 13.5. Brazil
  • 13.6. Argentina

14. Europe, Middle East & Africa DNA Fragments Market

  • 14.1. Introduction
  • 14.2. United Kingdom
  • 14.3. Germany
  • 14.4. France
  • 14.5. Russia
  • 14.6. Italy
  • 14.7. Spain
  • 14.8. United Arab Emirates
  • 14.9. Saudi Arabia
  • 14.10. South Africa
  • 14.11. Denmark
  • 14.12. Netherlands
  • 14.13. Qatar
  • 14.14. Finland
  • 14.15. Sweden
  • 14.16. Nigeria
  • 14.17. Egypt
  • 14.18. Turkey
  • 14.19. Israel
  • 14.20. Norway
  • 14.21. Poland
  • 14.22. Switzerland

15. Asia-Pacific DNA Fragments Market

  • 15.1. Introduction
  • 15.2. China
  • 15.3. India
  • 15.4. Japan
  • 15.5. Australia
  • 15.6. South Korea
  • 15.7. Indonesia
  • 15.8. Thailand
  • 15.9. Philippines
  • 15.10. Malaysia
  • 15.11. Singapore
  • 15.12. Vietnam
  • 15.13. Taiwan

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. Abbott Laboratories
    • 16.3.2. Agilent Technologies, Inc.
    • 16.3.3. Ansa Biotechnologies, Inc.
    • 16.3.4. Azenta Life Sciences
    • 16.3.5. Abcam plc
    • 16.3.6. DNA TwoPointO Inc.
    • 16.3.7. Eurofins Scientific SE
    • 16.3.8. Gene Universal, Inc.
    • 16.3.9. GenScript Biotech Corporation
    • 16.3.10. Illumina, Inc.
    • 16.3.11. Integrated DNA Technologies, Inc. by Danaher Corporation
    • 16.3.12. Merck KGaA
    • 16.3.13. Meridian Bioscience, Inc.
    • 16.3.14. Novartis AG
    • 16.3.15. Pacific Biosciences of California, Inc.
    • 16.3.16. QIAGEN N.V
    • 16.3.17. Synbio Technologies LLC
    • 16.3.18. Takara Co., Ltd.
    • 16.3.19. Thermo Fisher Scientific Inc.
    • 16.3.20. Twist Bioscience Corporation
    • 16.3.21. Synbio Technologies Private Limited
    • 16.3.22. Cell Signaling Technology, Inc..
    • 16.3.23. Bio-Rad Laboratories, Inc.
    • 16.3.24. SCSA Diagnostics Inc.
    • 16.3.25. Profacgen

17. ResearchAI

18. ResearchStatistics

19. ResearchContacts

20. ResearchArticles

21. Appendix

LIST OF FIGURES

  • FIGURE 1. DNA FRAGMENTS MARKET RESEARCH PROCESS
  • FIGURE 2. GLOBAL DNA FRAGMENTS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 3. GLOBAL DNA FRAGMENTS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 4. GLOBAL DNA FRAGMENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL DNA FRAGMENTS MARKET SIZE, BY TYPE, 2024 VS 2030 (%)
  • FIGURE 6. GLOBAL DNA FRAGMENTS MARKET SIZE, BY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 7. GLOBAL DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
  • FIGURE 8. GLOBAL DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL DNA FRAGMENTS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
  • FIGURE 10. GLOBAL DNA FRAGMENTS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
  • FIGURE 12. GLOBAL DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 13. GLOBAL DNA FRAGMENTS MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
  • FIGURE 14. GLOBAL DNA FRAGMENTS MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 15. AMERICAS DNA FRAGMENTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 16. AMERICAS DNA FRAGMENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 17. UNITED STATES DNA FRAGMENTS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
  • FIGURE 18. UNITED STATES DNA FRAGMENTS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA DNA FRAGMENTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA DNA FRAGMENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 21. ASIA-PACIFIC DNA FRAGMENTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 22. ASIA-PACIFIC DNA FRAGMENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 23. DNA FRAGMENTS MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 24. DNA FRAGMENTS MARKET, FPNV POSITIONING MATRIX, 2024
  • FIGURE 25. DNA FRAGMENTS MARKET: RESEARCHAI
  • FIGURE 26. DNA FRAGMENTS MARKET: RESEARCHSTATISTICS
  • FIGURE 27. DNA FRAGMENTS MARKET: RESEARCHCONTACTS
  • FIGURE 28. DNA FRAGMENTS MARKET: RESEARCHARTICLES

LIST OF TABLES

  • TABLE 1. DNA FRAGMENTS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL DNA FRAGMENTS MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL DNA FRAGMENTS MARKET SIZE, 2025-2030 (USD MILLION)
  • TABLE 5. GLOBAL DNA FRAGMENTS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL DNA FRAGMENTS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 7. GLOBAL DNA FRAGMENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL DNA FRAGMENTS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 9. GLOBAL DNA FRAGMENTS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL DNA FRAGMENTS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 11. GLOBAL DNA FRAGMENTS MARKET SIZE, BY DOUBLE-STRANDED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL DNA FRAGMENTS MARKET SIZE, BY DOUBLE-STRANDED, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 13. GLOBAL DNA FRAGMENTS MARKET SIZE, BY SINGLE-STRANDED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL DNA FRAGMENTS MARKET SIZE, BY SINGLE-STRANDED, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 15. GLOBAL DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 17. GLOBAL DNA FRAGMENTS MARKET SIZE, BY NATURAL DNA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL DNA FRAGMENTS MARKET SIZE, BY NATURAL DNA, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 19. GLOBAL DNA FRAGMENTS MARKET SIZE, BY SYNTHETIC DNA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL DNA FRAGMENTS MARKET SIZE, BY SYNTHETIC DNA, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 21. GLOBAL DNA FRAGMENTS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL DNA FRAGMENTS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 23. GLOBAL DNA FRAGMENTS MARKET SIZE, BY CHEMICAL SYNTHESIS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL DNA FRAGMENTS MARKET SIZE, BY CHEMICAL SYNTHESIS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 25. GLOBAL DNA FRAGMENTS MARKET SIZE, BY ENZYMATIC SYNTHESIS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL DNA FRAGMENTS MARKET SIZE, BY ENZYMATIC SYNTHESIS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 27. GLOBAL DNA FRAGMENTS MARKET SIZE, BY PCR BASED AMPLIFICATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL DNA FRAGMENTS MARKET SIZE, BY PCR BASED AMPLIFICATION, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 29. GLOBAL DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 31. GLOBAL DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 33. GLOBAL DNA FRAGMENTS MARKET SIZE, BY BIOINFORMATICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL DNA FRAGMENTS MARKET SIZE, BY BIOINFORMATICS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 35. GLOBAL DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 37. GLOBAL DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 39. GLOBAL DNA FRAGMENTS MARKET SIZE, BY MEDICAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL DNA FRAGMENTS MARKET SIZE, BY MEDICAL, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 41. GLOBAL DNA FRAGMENTS MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL DNA FRAGMENTS MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 43. GLOBAL DNA FRAGMENTS MARKET SIZE, BY THERAPEUTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL DNA FRAGMENTS MARKET SIZE, BY THERAPEUTICS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 45. GLOBAL DNA FRAGMENTS MARKET SIZE, BY MEDICAL, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL DNA FRAGMENTS MARKET SIZE, BY MEDICAL, 2025-2030 (USD MILLION)
  • TABLE 47. GLOBAL DNA FRAGMENTS MARKET SIZE, BY RESEARCH & DEVELOPMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL DNA FRAGMENTS MARKET SIZE, BY RESEARCH & DEVELOPMENT, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 49. GLOBAL DNA FRAGMENTS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL DNA FRAGMENTS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
  • TABLE 51. GLOBAL DNA FRAGMENTS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL DNA FRAGMENTS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 53. GLOBAL DNA FRAGMENTS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL DNA FRAGMENTS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 55. GLOBAL DNA FRAGMENTS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL DNA FRAGMENTS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 57. GLOBAL DNA FRAGMENTS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL DNA FRAGMENTS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 59. AMERICAS DNA FRAGMENTS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 60. AMERICAS DNA FRAGMENTS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 61. AMERICAS DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 62. AMERICAS DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 63. AMERICAS DNA FRAGMENTS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 64. AMERICAS DNA FRAGMENTS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 65. AMERICAS DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 66. AMERICAS DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 67. AMERICAS DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 68. AMERICAS DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 69. AMERICAS DNA FRAGMENTS MARKET SIZE, BY MEDICAL, 2018-2024 (USD MILLION)
  • TABLE 70. AMERICAS DNA FRAGMENTS MARKET SIZE, BY MEDICAL, 2025-2030 (USD MILLION)
  • TABLE 71. AMERICAS DNA FRAGMENTS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 72. AMERICAS DNA FRAGMENTS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
  • TABLE 73. AMERICAS DNA FRAGMENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 74. AMERICAS DNA FRAGMENTS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 75. UNITED STATES DNA FRAGMENTS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 76. UNITED STATES DNA FRAGMENTS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 77. UNITED STATES DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 78. UNITED STATES DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 79. UNITED STATES DNA FRAGMENTS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 80. UNITED STATES DNA FRAGMENTS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 81. UNITED STATES DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 82. UNITED STATES DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 83. UNITED STATES DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 84. UNITED STATES DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 85. UNITED STATES DNA FRAGMENTS MARKET SIZE, BY MEDICAL, 2018-2024 (USD MILLION)
  • TABLE 86. UNITED STATES DNA FRAGMENTS MARKET SIZE, BY MEDICAL, 2025-2030 (USD MILLION)
  • TABLE 87. UNITED STATES DNA FRAGMENTS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 88. UNITED STATES DNA FRAGMENTS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
  • TABLE 89. UNITED STATES DNA FRAGMENTS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
  • TABLE 90. UNITED STATES DNA FRAGMENTS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
  • TABLE 91. CANADA DNA FRAGMENTS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 92. CANADA DNA FRAGMENTS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 93. CANADA DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 94. CANADA DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 95. CANADA DNA FRAGMENTS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 96. CANADA DNA FRAGMENTS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 97. CANADA DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 98. CANADA DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 99. CANADA DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 100. CANADA DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 101. CANADA DNA FRAGMENTS MARKET SIZE, BY MEDICAL, 2018-2024 (USD MILLION)
  • TABLE 102. CANADA DNA FRAGMENTS MARKET SIZE, BY MEDICAL, 2025-2030 (USD MILLION)
  • TABLE 103. CANADA DNA FRAGMENTS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 104. CANADA DNA FRAGMENTS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
  • TABLE 105. MEXICO DNA FRAGMENTS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 106. MEXICO DNA FRAGMENTS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 107. MEXICO DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 108. MEXICO DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 109. MEXICO DNA FRAGMENTS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 110. MEXICO DNA FRAGMENTS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 111. MEXICO DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 112. MEXICO DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 113. MEXICO DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 114. MEXICO DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 115. MEXICO DNA FRAGMENTS MARKET SIZE, BY MEDICAL, 2018-2024 (USD MILLION)
  • TABLE 116. MEXICO DNA FRAGMENTS MARKET SIZE, BY MEDICAL, 2025-2030 (USD MILLION)
  • TABLE 117. MEXICO DNA FRAGMENTS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 118. MEXICO DNA FRAGMENTS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
  • TABLE 119. BRAZIL DNA FRAGMENTS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 120. BRAZIL DNA FRAGMENTS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 121. BRAZIL DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 122. BRAZIL DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 123. BRAZIL DNA FRAGMENTS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 124. BRAZIL DNA FRAGMENTS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 125. BRAZIL DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 126. BRAZIL DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 127. BRAZIL DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 128. BRAZIL DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 129. BRAZIL DNA FRAGMENTS MARKET SIZE, BY MEDICAL, 2018-2024 (USD MILLION)
  • TABLE 130. BRAZIL DNA FRAGMENTS MARKET SIZE, BY MEDICAL, 2025-2030 (USD MILLION)
  • TABLE 131. BRAZIL DNA FRAGMENTS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 132. BRAZIL DNA FRAGMENTS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
  • TABLE 133. ARGENTINA DNA FRAGMENTS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 134. ARGENTINA DNA FRAGMENTS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 135. ARGENTINA DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 136. ARGENTINA DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 137. ARGENTINA DNA FRAGMENTS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 138. ARGENTINA DNA FRAGMENTS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 139. ARGENTINA DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 140. ARGENTINA DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 141. ARGENTINA DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 142. ARGENTINA DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 143. ARGENTINA DNA FRAGMENTS MARKET SIZE, BY MEDICAL, 2018-2024 (USD MILLION)
  • TABLE 144. ARGENTINA DNA FRAGMENTS MARKET SIZE, BY MEDICAL, 2025-2030 (USD MILLION)
  • TABLE 145. ARGENTINA DNA FRAGMENTS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 146. ARGENTINA DNA FRAGMENTS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
  • TABLE 147. EUROPE, MIDDLE EAST & AFRICA DNA FRAGMENTS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 148. EUROPE, MIDDLE EAST & AFRICA DNA FRAGMENTS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA DNA FRAGMENTS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA DNA FRAGMENTS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 153. EUROPE, MIDDLE EAST & AFRICA DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 154. EUROPE, MIDDLE EAST & AFRICA DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 155. EUROPE, MIDDLE EAST & AFRICA DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 156. EUROPE, MIDDLE EAST & AFRICA DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 157. EUROPE, MIDDLE EAST & AFRICA DNA FRAGMENTS MARKET SIZE, BY MEDICAL, 2018-2024 (USD MILLION)
  • TABLE 158. EUROPE, MIDDLE EAST & AFRICA DNA FRAGMENTS MARKET SIZE, BY MEDICAL, 2025-2030 (USD MILLION)
  • TABLE 159. EUROPE, MIDDLE EAST & AFRICA DNA FRAGMENTS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 160. EUROPE, MIDDLE EAST & AFRICA DNA FRAGMENTS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
  • TABLE 161. EUROPE, MIDDLE EAST & AFRICA DNA FRAGMENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 162. EUROPE, MIDDLE EAST & AFRICA DNA FRAGMENTS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 163. UNITED KINGDOM DNA FRAGMENTS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 164. UNITED KINGDOM DNA FRAGMENTS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 165. UNITED KINGDOM DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 166. UNITED KINGDOM DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 167. UNITED KINGDOM DNA FRAGMENTS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 168. UNITED KINGDOM DNA FRAGMENTS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 169. UNITED KINGDOM DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 170. UNITED KINGDOM DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 171. UNITED KINGDOM DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 172. UNITED KINGDOM DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 173. UNITED KINGDOM DNA FRAGMENTS MARKET SIZE, BY MEDICAL, 2018-2024 (USD MILLION)
  • TABLE 174. UNITED KINGDOM DNA FRAGMENTS MARKET SIZE, BY MEDICAL, 2025-2030 (USD MILLION)
  • TABLE 175. UNITED KINGDOM DNA FRAGMENTS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 176. UNITED KINGDOM DNA FRAGMENTS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
  • TABLE 177. GERMANY DNA FRAGMENTS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 178. GERMANY DNA FRAGMENTS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 179. GERMANY DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 180. GERMANY DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 181. GERMANY DNA FRAGMENTS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 182. GERMANY DNA FRAGMENTS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 183. GERMANY DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 184. GERMANY DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 185. GERMANY DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 186. GERMANY DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 187. GERMANY DNA FRAGMENTS MARKET SIZE, BY MEDICAL, 2018-2024 (USD MILLION)
  • TABLE 188. GERMANY DNA FRAGMENTS MARKET SIZE, BY MEDICAL, 2025-2030 (USD MILLION)
  • TABLE 189. GERMANY DNA FRAGMENTS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 190. GERMANY DNA FRAGMENTS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
  • TABLE 191. FRANCE DNA FRAGMENTS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 192. FRANCE DNA FRAGMENTS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 193. FRANCE DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 194. FRANCE DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 195. FRANCE DNA FRAGMENTS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 196. FRANCE DNA FRAGMENTS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 197. FRANCE DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 198. FRANCE DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 199. FRANCE DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 200. FRANCE DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 201. FRANCE DNA FRAGMENTS MARKET SIZE, BY MEDICAL, 2018-2024 (USD MILLION)
  • TABLE 202. FRANCE DNA FRAGMENTS MARKET SIZE, BY MEDICAL, 2025-2030 (USD MILLION)
  • TABLE 203. FRANCE DNA FRAGMENTS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 204. FRANCE DNA FRAGMENTS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
  • TABLE 205. RUSSIA DNA FRAGMENTS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 206. RUSSIA DNA FRAGMENTS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 207. RUSSIA DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 208. RUSSIA DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 209. RUSSIA DNA FRAGMENTS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 210. RUSSIA DNA FRAGMENTS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 211. RUSSIA DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 212. RUSSIA DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 213. RUSSIA DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 214. RUSSIA DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 215. RUSSIA DNA FRAGMENTS MARKET SIZE, BY MEDICAL, 2018-2024 (USD MILLION)
  • TABLE 216. RUSSIA DNA FRAGMENTS MARKET SIZE, BY MEDICAL, 2025-2030 (USD MILLION)
  • TABLE 217. RUSSIA DNA FRAGMENTS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 218. RUSSIA DNA FRAGMENTS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
  • TABLE 219. ITALY DNA FRAGMENTS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 220. ITALY DNA FRAGMENTS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 221. ITALY DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 222. ITALY DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 223. ITALY DNA FRAGMENTS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 224. ITALY DNA FRAGMENTS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 225. ITALY DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 226. ITALY DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 227. ITALY DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 228. ITALY DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 229. ITALY DNA FRAGMENTS MARKET SIZE, BY MEDICAL, 2018-2024 (USD MILLION)
  • TABLE 230. ITALY DNA FRAGMENTS MARKET SIZE, BY MEDICAL, 2025-2030 (USD MILLION)
  • TABLE 231. ITALY DNA FRAGMENTS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 232. ITALY DNA FRAGMENTS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
  • TABLE 233. SPAIN DNA FRAGMENTS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 234. SPAIN DNA FRAGMENTS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 235. SPAIN DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 236. SPAIN DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 237. SPAIN DNA FRAGMENTS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 238. SPAIN DNA FRAGMENTS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 239. SPAIN DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 240. SPAIN DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 241. SPAIN DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 242. SPAIN DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 243. SPAIN DNA FRAGMENTS MARKET SIZE, BY MEDICAL, 2018-2024 (USD MILLION)
  • TABLE 244. SPAIN DNA FRAGMENTS MARKET SIZE, BY MEDICAL, 2025-2030 (USD MILLION)
  • TABLE 245. SPAIN DNA FRAGMENTS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 246. SPAIN DNA FRAGMENTS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
  • TABLE 247. UNITED ARAB EMIRATES DNA FRAGMENTS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 248. UNITED ARAB EMIRATES DNA FRAGMENTS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 249. UNITED ARAB EMIRATES DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 250. UNITED ARAB EMIRATES DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 251. UNITED ARAB EMIRATES DNA FRAGMENTS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 252. UNITED ARAB EMIRATES DNA FRAGMENTS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 253. UNITED ARAB EMIRATES DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 254. UNITED ARAB EMIRATES DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 255. UNITED ARAB EMIRATES DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 256. UNITED ARAB EMIRATES DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 257. UNITED ARAB EMIRATES DNA FRAGMENTS MARKET SIZE, BY MEDICAL, 2018-2024 (USD MILLION)
  • TABLE 258. UNITED ARAB EMIRATES DNA FRAGMENTS MARKET SIZE, BY MEDICAL, 2025-2030 (USD MILLION)
  • TABLE 259. UNITED ARAB EMIRATES DNA FRAGMENTS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 260. UNITED ARAB EMIRATES DNA FRAGMENTS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
  • TABLE 261. SAUDI ARABIA DNA FRAGMENTS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 262. SAUDI ARABIA DNA FRAGMENTS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 263. SAUDI ARABIA DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 264. SAUDI ARABIA DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 265. SAUDI ARABIA DNA FRAGMENTS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 266. SAUDI ARABIA DNA FRAGMENTS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 267. SAUDI ARABIA DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 268. SAUDI ARABIA DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 269. SAUDI ARABIA DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 270. SAUDI ARABIA DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 271. SAUDI ARABIA DNA FRAGMENTS MARKET SIZE, BY MEDICAL, 2018-2024 (USD MILLION)
  • TABLE 272. SAUDI ARABIA DNA FRAGMENTS MARKET SIZE, BY MEDICAL, 2025-2030 (USD MILLION)
  • TABLE 273. SAUDI ARABIA DNA FRAGMENTS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 274. SAUDI ARABIA DNA FRAGMENTS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
  • TABLE 275. SOUTH AFRICA DNA FRAGMENTS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 276. SOUTH AFRICA DNA FRAGMENTS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 277. SOUTH AFRICA DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 278. SOUTH AFRICA DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 279. SOUTH AFRICA DNA FRAGMENTS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 280. SOUTH AFRICA DNA FRAGMENTS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 281. SOUTH AFRICA DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 282. SOUTH AFRICA DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 283. SOUTH AFRICA DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 284. SOUTH AFRICA DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 285. SOUTH AFRICA DNA FRAGMENTS MARKET SIZE, BY MEDICAL, 2018-2024 (USD MILLION)
  • TABLE 286. SOUTH AFRICA DNA FRAGMENTS MARKET SIZE, BY MEDICAL, 2025-2030 (USD MILLION)
  • TABLE 287. SOUTH AFRICA DNA FRAGMENTS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 288. SOUTH AFRICA DNA FRAGMENTS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
  • TABLE 289. DENMARK DNA FRAGMENTS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 290. DENMARK DNA FRAGMENTS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 291. DENMARK DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 292. DENMARK DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 293. DENMARK DNA FRAGMENTS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 294. DENMARK DNA FRAGMENTS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 295. DENMARK DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 296. DENMARK DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 297. DENMARK DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 298. DENMARK DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 299. DENMARK DNA FRAGMENTS MARKET SIZE, BY MEDICAL, 2018-2024 (USD MILLION)
  • TABLE 300. DENMARK DNA FRAGMENTS MARKET SIZE, BY MEDICAL, 2025-2030 (USD MILLION)
  • TABLE 301. DENMARK DNA FRAGMENTS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 302. DENMARK DNA FRAGMENTS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
  • TABLE 303. NETHERLANDS DNA FRAGMENTS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 304. NETHERLANDS DNA FRAGMENTS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 305. NETHERLANDS DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 306. NETHERLANDS DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 307. NETHERLANDS DNA FRAGMENTS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 308. NETHERLANDS DNA FRAGMENTS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 309. NETHERLANDS DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 310. NETHERLANDS DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 311. NETHERLANDS DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 312. NETHERLANDS DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 313. NETHERLANDS DNA FRAGMENTS MARKET SIZE, BY MEDICAL, 2018-2024 (USD MILLION)
  • TABLE 314. NETHERLANDS DNA FRAGMENTS MARKET SIZE, BY MEDICAL, 2025-2030 (USD MILLION)
  • TABLE 315. NETHERLANDS DNA FRAGMENTS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 316. NETHERLANDS DNA FRAGMENTS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
  • TABLE 317. QATAR DNA FRAGMENTS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 318. QATAR DNA FRAGMENTS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 319. QATAR DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 320. QATAR DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 321. QATAR DNA FRAGMENTS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 322. QATAR DNA FRAGMENTS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 323. QATAR DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 324. QATAR DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 325. QATAR DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 326. QATAR DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 327. QATAR DNA FRAGMENTS MARKET SIZE, BY MEDICAL, 2018-2024 (USD MILLION)
  • TABLE 328. QATAR DNA FRAGMENTS MARKET SIZE, BY MEDICAL, 2025-2030 (USD MILLION)
  • TABLE 329. QATAR DNA FRAGMENTS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 330. QATAR DNA FRAGMENTS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
  • TABLE 331. FINLAND DNA FRAGMENTS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 332. FINLAND DNA FRAGMENTS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 333. FINLAND DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 334. FINLAND DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 335. FINLAND DNA FRAGMENTS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 336. FINLAND DNA FRAGMENTS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 337. FINLAND DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 338. FINLAND DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 339. FINLAND DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 340. FINLAND DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 341. FINLAND DNA FRAGMENTS MARKET SIZE, BY MEDICAL, 2018-2024 (USD MILLION)
  • TABLE 342. FINLAND DNA FRAGMENTS MARKET SIZE, BY MEDICAL, 2025-2030 (USD MILLION)
  • TABLE 343. FINLAND DNA FRAGMENTS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 344. FINLAND DNA FRAGMENTS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
  • TABLE 345. SWEDEN DNA FRAGMENTS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 346. SWEDEN DNA FRAGMENTS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 347. SWEDEN DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 348. SWEDEN DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 349. SWEDEN DNA FRAGMENTS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 350. SWEDEN DNA FRAGMENTS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 351. SWEDEN DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 352. SWEDEN DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 353. SWEDEN DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 354. SWEDEN DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 355. SWEDEN DNA FRAGMENTS MARKET SIZE, BY MEDICAL, 2018-2024 (USD MILLION)
  • TABLE 356. SWEDEN DNA FRAGMENTS MARKET SIZE, BY MEDICAL, 2025-2030 (USD MILLION)
  • TABLE 357. SWEDEN DNA FRAGMENTS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 358. SWEDEN DNA FRAGMENTS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
  • TABLE 359. NIGERIA DNA FRAGMENTS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 360. NIGERIA DNA FRAGMENTS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 361. NIGERIA DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 362. NIGERIA DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 363. NIGERIA DNA FRAGMENTS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 364. NIGERIA DNA FRAGMENTS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 365. NIGERIA DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 366. NIGERIA DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 367. NIGERIA DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 368. NIGERIA DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 369. NIGERIA DNA FRAGMENTS MARKET SIZE, BY MEDICAL, 2018-2024 (USD MILLION)
  • TABLE 370. NIGERIA DNA FRAGMENTS MARKET SIZE, BY MEDICAL, 2025-2030 (USD MILLION)
  • TABLE 371. NIGERIA DNA FRAGMENTS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 372. NIGERIA DNA FRAGMENTS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
  • TABLE 373. EGYPT DNA FRAGMENTS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 374. EGYPT DNA FRAGMENTS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 375. EGYPT DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-20